在全身性红斑狼中,血清NLRC3水平:与临床特征的相关性
Wengen Li1, Xiaodong Gu2, Sudong Liu2
1Department of Rheumatology and Immunology, Meizhou People's Hospital (Huangtang Hospital), Meizhou, China. ligen0072008@163.com.
Clinical and experimental rheumatology
|October 3, 2025
概括
具有酶激活和招募域3 (NLRC3) 的核酸寡合化域 (NOD) 类受体的血清水平在活跃的系统性红斑狼 (SLE) 患者中较低. 下NLRC3与疾病活性有关,这表明它可能是活跃SLE的生物标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 分子生物学分子生物学
背景情况:
- 系统性红斑狼 (SLE) 是一种具有复杂病源性的慢性自身免疫性疾病.
- 具有酶激活和招募域3 (NLRC3) 的核酸寡合化域 (NOD) 类受体在SLE病变发生中的作用尚不清楚.
研究的目的:
- 在患有活性SLE,狼低病活性状态 (LLDAS) 和健康对照患者中检查血清NLRC3水平.
- 探索血清NLRC3水平与SLE的临床特征之间的相关性.
- 评估NLRC3对活性SLE的诊断潜力.
主要方法:
- 一项涉及60名活跃SLE患者,60名LLDAS SLE患者和50名健康对照者的横截面研究.
- 测量了血清NLRC3水平.
- 收集了临床数据,包括疾病活动标志物.
- 进行了斯皮尔曼相关性和接收器操作特征 (ROC) 曲线分析.
主要成果:
- 与LLDAS SLE患者和健康对照患者相比,活跃SLE患者的血清NLRC3水平显著降低.
- 在活跃的SLE患者中,较低的NLRC3水平与发烧,皮疹和血液学参与有关.
- NLRC3水平与发烧,皮疹,白血病和BAFF有负相关性,与补充C3.3有正相关性.
- 根据ROC分析,NLRC3可以将活跃的SLE与LLDAS SLE区分开来,AUC为0.665.
结论:
- 在活跃的SLE患者中,血清NLRC3水平显著降低.
- NLRC3水平与SLE疾病活动的关键临床参数相关.
- NLRC3显示出作为生物标志物的潜力,用于识别活跃的SLE.
更多相关视频
08:40An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
Published on: March 14, 2016
20.1K
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
489
相关概念视频
01:24Nephrotic Syndrome III : Nursing Management
279
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
279
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
538
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
538